Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 7, 2014, Pages 1375-1384

  Lu, Ching Chu ^a   Wu, Vin Cent ^a   Wu, Kwan Dun ^a   Liu, Kao Lang ^a   Lin, Wei Chou ^a   Cheng, Mei Fang ^a   Tzen, Kai Yuan ^a   Yen, Ruoh Fang ^a   Lin, Yen Hung ^b   Ho, Yi Luwn ^b   Chang, Hung Wei ^b   Lin, Lian Yu ^b   Hu, Fu Chang ^b   Wang, Shuo Meng ^b   Huang, Kuo How ^b   Chen, Yung Ming ^b   Kuo, Chin Chi ^b   Chueh, Shih Chieh ^b   Chang, Fang Chi ^b   Liao, Shih Cheng ^b   Hsieh, Bor Sen ^b   more..

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Internal Medicine National Taiwan University Hospital National Taiwan University College of Medicine ^*

Author keywords

Adrenalectomy; NP 59; Outcome; Primary aldosteronism; Semiquantification

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; 6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL;

ADENOMA; ADRENAL GLAND; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPLASIA; HYPERTENSION; LIVER; MALE; MIDDLE AGED; PATHOLOGY; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; YOUNG ADULT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; HYPERALDOSTERONISM; MULTIMODAL IMAGING; OBSERVER VARIATION; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; TREATMENT OUTCOME;

ADENOMA; ADOSTEROL; ADRENALECTOMY; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903698586     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2692-z     Document Type: Article

References (39)

1. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 2004;89(9):4221-6. (Pubitemid 39244414)
2. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol 2006;48(11):2293-300. (Pubitemid 44873058)
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45(8):1243-8. (Pubitemid 40523144)
4. Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol 2003;169(1):32-5. (Pubitemid 35461542)
5. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens 2001;19(3):353-61. (Pubitemid 32195369)
6. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86(3):1066-71. (Pubitemid 32322983)
7. Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 2003;88(8):3637-44. (Pubitemid 37034507)
8. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008;26(5):989-97. (Pubitemid 351520987)
9. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 2012;97(5):1606-14.
10. Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, et al. Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension 2011;57(5):990-5.
11. Counsell RE, Ranada VV, Blair RJ, Beierwaltes SH, Weinhold PA. Tumor localizing agents IX. Radioiodinated cholesterol. Steroids 1970;16(3):317-28.
12. Beierwaltes WH, Lieberman LM, Ansari AN, Nishiyama H. Visualization of human adrenal glands in vivo by scintillation scanning. JAMA 1971;216(2):275-7.
13. Sarkar SD, Beierwaltes H, Ice RD, Basmadjian GP, Hetzel KR, Kennedy WP, et al. A new and superior adrenal scanning agent, NP-59. J Nucl Med 1975;16(11):1038-42.
14. Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, et al. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med 2009;50(10):1631-7.
15. Steichen O, Zinzindohoué F, Plouin PF, Amar L. Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 2012;44(3):221-7.
16. TAIPAI Study Group, Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009;54(4):665-73.
17. Weisbrod AB, Webb RC, Mathur A, Barak S, Abraham SB, Nilubol N, et al. Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism. Ann Surg Oncol 2013;20:753-8.
18. Amar L, Plouin PF, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010;5:9.
19. La Cava G, Imperiale A, Olianti C, Gheri GR, Ladu C, Mannelli M, et al. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. J Nucl Med 2003;44(7):1057-64. (Pubitemid 39663380)
20. Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 2011;12(3):348-57.
21. Wu VC, Chueh SC, Chang HW, Lin WC, Liu KL, Li HY, et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM 2008;101(1):13-22.
22. Liao CH, Chueh SC, Lai MK, Hsiao PJ, Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab 2006;91(8):3080-3. (Pubitemid 44271759)
23. Gross MD, Valk TW, Swanson DP, Thrall JH, Grekin RJ, Beirewaltes WH. The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin Nucl Med 1981;11(2):128-48.
24. Gross MD, Freitas JE, Swanson DP, Brady T, Beierwaltes WH. The normal dexamethasone-suppression adrenal scintiscan. J Nucl Med 1979;20(11):1131-5. (Pubitemid 10164041)
25. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007;50(5):911-8. (Pubitemid 350287534)
26. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93(9):3266-81.
27. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005;71(10):864-9.
28. Pang TC, Bambach C, Monaghan JC, Sidhu SB, Bune A, Delbridge LW, et al. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007;77(9):768-73.
29. Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008;51(5):1366-71. (Pubitemid 351555951)
30. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin PF. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008;26(9):1816-23.
31. Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M, et al. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 1992;112(6):987-93. (Pubitemid 23008223)
32. Proye CA, Mulliez EA, Carnaille BM, Lecomte-Houcke M, Decoulx M, Wémeau JL, et al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 1998;124(6):1128-33. (Pubitemid 28555205)
33. Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001;135(4):258-61. (Pubitemid 32799339)
34. Waldmann J, Maurer L, Holler J, Kann PH, Ramaswamy A, Bartsch DK, et al. Outcome of surgery for primary hyperaldosteronism. World J Surg 2011;35(11):2422-7.
35. Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL. Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience. J Clin Hypertens (Greenwich) 2009;11(6):316-23.
36. Quillo AR, Grant CS, Thompson GB, Farley DR, Richards ML, Young WF. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. J Am Coll Surg 2011;213(1):106-12. discussion 112-23.
37. Walz MK, Gwosdz R, Levin SL, Alesina PF, Suttorp AC, Metz KA, et al. Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 2008;32(5):847-53.
38. Hwang I, Balingit AG, Georgitis WJ, Sisson JC, Shapiro B. Adrenocortical SPECT using iodine-131 NP-59. J Nucl Med 1998;39(8):1460-3. (Pubitemid 28373579)
39. Ishimura J, Kawanaka M, Fukuchi M. Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol. Clin Nucl Med 1989;14(4):278-81. (Pubitemid 19105355)